טוען...
Customizing Monoclonal Antibodies for the Treatment of Methamphetamine Abuse: Current and Future Applications
Monoclonal antibody-based medications designed to bind (+)-methamphetamine (METH) with high affinity are among the newest approaches to the treatment of METH abuse, and the associated medical complications. The potential clinical indications for these medications include treatment of overdose, reduc...
שמור ב:
| הוצא לאור ב: | Adv Pharmacol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4491432/ https://ncbi.nlm.nih.gov/pubmed/24484976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/B978-0-12-420118-7.00003-2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|